Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11003 results:
[ Συντάκτης(Asc)] Τίτλος Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zegkos, T., Parcharidou D., Ntelios D., Efthimiadis G., & Karvounis H. (2018).  The Prognostic Implications of Two-Dimensional Speckle Tracking Echocardiography in Hypertrophic Cardiomyopathy: Current and Future Perspectives.. Cardiol Rev. 26(3), 130-136.
Zecevic, N., Arsenijevic V., Manolakos E., Papoulidis I., Theocharis G., Sartsidis A., et al. (2020).  New Compound Heterozygous Splice Site Mutations of the Skeletal Muscle Ryanodine Receptor () Gene Manifest Fetal Akinesia: A Linkage with Congenital Myopathies.. Mol Syndromol. 11(2), 104-109.
Zavos, C., Kountouras J., Deretzi G., Tsona A., Polyzos S. A., Mantzoukis K., et al. (2012).  Hpn protein as a mediator between Helicobacter pylori infection and Alzheimer's disease in sub-populations worldwide.. Med Hypotheses. 78(2), 349-50.
Zavos, C., Kountouras J., Katsinelos P., Polyzos S. A., Deretzi G., Zavos N., et al. (2011).  Association between Helicobacter pylori infection and fibromyalgia syndrome.. Clin Rheumatol. 30(2), 301-2.
Zavos, A., Daponte A., Garas A., Verykouki C., Papanikolaou E., Anifandis G., et al. (2013).  Double versus single homologous intrauterine insemination for male factor infertility: a systematic review and meta-analysis.. Asian J Androl. 15(4), 533-8.
Zavos, C., Kountouras J., Katsinelos P., Polyzos S. A., Deretzi G., Zavos N., et al. (2011).  Modern industrialization may increase primary open-angle glaucoma prevalence through easier transmission of Helicobacter pylori infection.. Med Hypotheses. 76(5), 766-7.
Zavos, C., Kountouras J., Katsinelos P., Polyzos S. A., Deretzi G., Zavos N., et al. (2011).  Low aqueous humor ghrelin levels in open-angle glaucoma patients may correlate with Helicobacter pylori-associated apoptotic mechanisms.. Hippokratia. 15(3), 287-8.
Zarpalas, D., Gkontra P., Daras P., & Maglaveras N. (2014).  Gradient-based reliability maps for ACM-based segmentation of hippocampus.. IEEE Trans Biomed Eng. 61(4), 1015-26.
Zarogoulidou, V., Panagopoulou E., Papakosta D., Petridis D., Porpodis K., Zarogoulidis K., et al. (2015).  Estimating the direct and indirect costs of lung cancer: a prospective analysis in a Greek University Pulmonary Department.. J Thorac Dis. 7(Suppl 1), S12-9.
Zarogoulidis, P., Kioumis I., Lampaki S., Organtzis J., Porpodis K., Spyratos D., et al. (2014).  Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol.. Drug Des Devel Ther. 8, 1065-72.
Zarogoulidis, P., Petanidis S., Kioseoglou E., Domvri K., Anestakis D., & Zarogoulidis K. (2015).  MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.. Cell Signal. 27(8), 1576-88.
Zarogoulidis, P., Pataka A., Terzi E., Hohenforst-Schmidt W., Machairiotis N., Huang H., et al. (2013).  Intensive care unit and lung cancer: when should we intubate?. J Thorac Dis. 5 Suppl 4, S407-12.
Zarogoulidis, K., Papaiwannou A., Lazaridis G., Karavergou A., Lampaki S., Baka S., et al. (2015).  Pneumothorax from diagnosis to treatment, hands on course: Part II.. Ann Transl Med. 3(3), 41.
Zarogoulidis, P., Papanas N., Kouliatsis G., Spyratos D., Zarogoulidis K., & Maltezos E. (2011).  Inhaled insulin: too soon to be forgotten?. J Aerosol Med Pulm Drug Deliv. 24(5), 213-23.
Zarogoulidis, K., Mylonaki E., Kakavelas P., Zarogoulidis P., Tsiouda T., Rapti E., et al. (2009).  Topotecan-carboplatin-etoposide combination as 1st line treatment in patients with small cell lung cancer.. Lung Cancer. 66(2), 226-30.
Zarogoulidis, P., Chinelis P., Efthymiou C., Athanasiadou A., Mpikos V., Papatsibas G., et al. (2017).  EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50.. Respir Med Case Rep. 22, 7-10.
Zarogoulidis, P., Huang H., Yang M., Zhou J., Jiao Y., Wang Q., et al. (2020).  Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS?. J Cancer. 11(6), 1606-1613.
Zarogoulidis, P., Papanas N., Kioumis I., Chatzaki E., Maltezos E., & Zarogoulidis K. (2012).  Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.. Eur J Clin Pharmacol. 68(5), 479-503.
Zarogoulidis, P., Glaros D., Kontakiotis T., Froudarakis M., Kioumis I., Kouroumichakis I., et al. (2012).  Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections.. Int J Gen Med. 5, 175-82.
Zarogoulidis, P., Tsakiridis K., Kioumis I., & Zarogoulidis K. (2014).  Cardiothoracic diseases: basic treatment.. J Thorac Dis. 6 Suppl 1, S1.
Zarogoulidis, P., Tsakiridis K., & Zarogoulidis K. (2013).  Lung cancer: an update on current and future diagnostic and treatment techniques.. J Thorac Dis. 5 Suppl 4, S341.
Zarogoulidis, P., Tryfon S., Sapalidis K., Tsakiridis K., Baka S., Huang H., et al. (2020).  Bronchial HPV; the good the bad and the unknown.. Respir Med Case Rep. 30, 101053.
Zarogoulidis, P., Darwiche K., Yarmus L., Spyratos D., Secen N., Hohenforst-Schmidt W., et al. (2014).  Defense mechanisms of the respiratory system and aerosol production systems.. Med Chem. 10(2), 123-36.
Zarogoulidis, P., Hohenforst-Schmidt W., Huang H., Sahpatzidou D., Freitag L., Sakkas L., et al. (2014).  A gene therapy induced emphysema model and the protective role of stem cells.. Diagn Pathol. 9, 195.
Zarogoulidis, P., Huang H., Bai C., Kosmidis C., Porpodis K., Kallianos A., et al. (2018).  A new mode of ventilation for interventional pulmonology. A case with EBUS-TBNA and debulking.. Respir Med Case Rep. 23, 38-42.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές